[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369167-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369167-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","l-glutaminase-synthesis-by-klebsiella-pneumoniae-as-kp-23-efficacy-against-human-hepatocellular-and-breast-cancer-cell-lines","L-glutaminase synthesis by Klebsiella pneumoniae (AS KP 23) - efficacy against human hepatocellular and breast cancer cell lines","","Cancer survival and proliferation rely heavily on glutamine. Glutamine metabolism provides carbon for metabolite and lipid synthesis via the TCA cycle and nitrogen for amino acids and nucleotides, making glutamine-targeting a rationale for cancer therapy. L-glutaminase removes L-glutamine from cancerous cells and has been studied for antitumor effects across multiple models, including reported enzyme efficacy measured by cell viability assays and IC50 values, supporting its potential as an alternative to chemotherapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/l-glutaminase-synthesis-by-klebsiella-pneumoniae-as-kp-23-efficacy-against-human-hepatocellular-and-breast-cancer-cell-lines/369167/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/l-glutaminase-synthesis-by-klebsiella-pneumoniae-as-kp-23-efficacy-against-human-hepatocellular-and-breast-cancer-cell-lines/369167.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s central aim regarding L-glutaminase?","Question",{"text":63,"@type":64},"To synthesize and assess L-glutaminase produced by Klebsiella pneumoniae (AS KP 23), and evaluate its effectiveness against human hepatocellular and breast cancer cell lines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the Klebsiella pneumoniae AS KP 23 strain identified?",{"text":68,"@type":64},"The bacterium was extracted from human stool samples and identified using morphological, biochemical, and molecular methods, with the 16S rRNA gene showing 100% identity to Klebsiella pneumoniae.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key anticancer and enzyme characterization findings?",{"text":72,"@type":64},"The purified enzyme showed cytotoxic effects against HepG-2 and reduced viability of HeLa cells in a dose-dependent manner. It also exhibited measured properties including SDS-PAGE subunit size (~97 kDa), purification fold (1.33-fold), and a broad pH/temperature activity/stability profile.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369167,1790283876,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Abdel-Hafez et al. BMC Microbiology (2025) 25:62  \n[https://doi.org/10.1186/s12866-025-03773-3](https://doi.org/10.1186/s12866-025-03773-3)  \nBMC Microbiology  \nRESEARCH Open Access  \nL-glutaminase synthesis by Klebsiella pneumoniae (AS KP 23) isolated from clinical strain, and its efficacy against human hepatocellular and breast cancer cell lines  \nLina J. Abdel-Hafez 1, EmanY. T. Elariny2, Asmaa E. Ibrahim2 and Mahmoud E. F. Abdel-Haliem2*  \nAbstract  \nBackground Cancer is a major cause of morbidity and mortality worldwide. The proliferation of cancer cells depends largely on glutamine for survival and proliferation. Glutamine serves as a carbon source for the synthesis of metabolites and lipids via theTCA cycle, as well as a source of nitrogen for the synthesis of amino acids and nucleotides. Recently, the role of glutamine metabolism in cancer has been explored in many studies. Therefore, it provides a scientific relationship for targeting glutamine metabolism for cancer treatment. L-glutaminase which is a powerful anticancer medication that is widely used around the world, works by removing L-glutamine from cancerous cells. L-glutaminase has been cited as the most potent molecule that inhibits the proliferation of cancer cells, which significantly raises the possible applicability of cancer therapy and the possibility of its application as an alternative drug to chemotherapy. The first investigation into the antitumor property of L-glutaminase revealed its inhibitory effect on the growth of Gardner lymphosarcoma (6C3HED) and L-1210 leukemia cells. In the same study, glutaminase from Pseudomonas spp., in combination with azaserine enhanced the degree of tumor growth inhibition. Subsequently, L-glutaminase was administered intravenously in patients with acute lymphoblastic leukemia and acute myeloid leukemia. Recently, a purified L-glutaminase from Streptomyces sp. D214 was shown to be the most effective, with an IC50 value of 10 mg/ml against the MCF-7 tumor cell line. Also, various in vitro studies have revealed that the activity of glutaminase against the proliferation of tumor cell lines using the MTT (3-(4,5-dimethylthiazol- 2-yl)-2, 5-diphenyltetrazolium bromide) cell proliferation assay. Alcaligenes faecalis KLU102 glutaminase was able to reduce the viability of HeLa cells in a dose-dependent manner, with an IC50 value of 12.5 mg/ml within 24 h.  \nResults In this study, a bacterium extracellular from human stool samples was extracted and identified using morphological, biochemical, and molecular methods. The 16 S rRNA gene was 100% identical to the sequence from Klebsiella pneumoniae and was submitted to GenBank under accession number OQ703039 . Thus, this strain was named Klebsiella pneumoniae AS KP 23. Further kinetic studies on the purified enzyme were performed. In addition, the pH stability ofthe L-glutaminase enzyme was slightly affected over the pH range of 7.0–9.0 after 2 h of preincubation, and the rate of thermal inactivation ofthe L-glutaminase enzyme increased with higher temperatures  \n*Correspondence:  \nMahmoud E. F. Abdel-Haliem [Farrag1999@yahoo.com](Farrag1999@yahoo.com); [mfarrag@zu.edu.eg](mfarrag@zu.edu.eg)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will ne","cbCaiacKjgcJg09F","https://ap.wps.com/l/cbCaiacKjgcJg09F","pdf",2431027,17,"English","# Abstract\n# Background\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the study’s central aim regarding L-glutaminase?\",\"answer\":\"To synthesize and assess L-glutaminase produced by Klebsiella pneumoniae (AS KP 23), and evaluate its effectiveness against human hepatocellular and breast cancer cell lines.\"},{\"question\":\"How was the Klebsiella pneumoniae AS KP 23 strain identified?\",\"answer\":\"The bacterium was extracted from human stool samples and identified using morphological, biochemical, and molecular methods, with the 16S rRNA gene showing 100% identity to Klebsiella pneumoniae.\"},{\"question\":\"What were the key anticancer and enzyme characterization findings?\",\"answer\":\"The purified enzyme showed cytotoxic effects against HepG-2 and reduced viability of HeLa cells in a dose-dependent manner. It also exhibited measured properties including SDS-PAGE subunit size (~97 kDa), purification fold (1.33-fold), and a broad pH/temperature activity/stability profile.\"}]","L-glutaminase synthesis by Klebsiella pneumoniae (AS KP 23) - efficacy against human hepatocellular and breast cancer cell lines | PDF",1790181136,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e9531a4bd541cdc5f8a0c592451d41f.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7786220f7bf911dc2df419487c8cc43f.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e819cf17fce860daba8011252d0de56.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87f9b8c12525a444055ecfa3af3ab4ba.webp",980,1306]